Early next year, Zimbabwe is set to commence its initial rollout of a long-acting injectable HIV prevention drug, with approximately 46,500 individuals slated to begin treatment. This is the first injectable drug for pre-exposure prophylaxis of HIV (PrEP), with a course consisting of two injections per year providing protection for six months. According to The […]
Install the app today!
Get in touch with us
Reach out to the Hayti team about
collaborating or working together.